# The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients.

> **NCT03334578** · PHASE4 · WITHDRAWN · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's**

## Conditions studied

- Gastroschisis
- Bowel Obstruction
- Birth Defect

## Interventions

- **DRUG:** Gastrografin

## Key facts

- **NCT ID:** NCT03334578
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-08-03
- **Primary completion:** 2020-12-17
- **Final completion:** 2020-12-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2023-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03334578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03334578, "The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03334578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*